Cytochrome P450 2E1 genotype and the susceptibility to antituberculosis drug‐induced hepatitis
Yi‐Shin Huang, Herng‐Der Chern, Wei‐Juin Su, Jaw‐Ching Wu, Shi‐Chuan Chang, Chi‐Huei Chiang, Full‐Young Chang, Shou‐Dong Lee – 30 December 2003 – Most cases with antituberculosis drug‐induced hepatitis have been attributed to isoniazid. Isoniazid is metabolized by hepatic N‐acetyltransferase (NAT) and cytochrome P450 2E1 (CYP2E1) to form hepatotoxins. However, the role of CYP2E1 in this hepatotoxicity has not yet been reported. The aim of this study was to evaluate whether the polymorphism of the CYP2E1 gene is associated with antituberculosis drug‐induced hepatitis.